公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2020 | A 27-GHz Continuous Class-F Power Amplifier with AM-PM Compensation in 65 nm CMOS Process | Lin Y.-T; Chen Y.-M; Chen C.-N; HUEI WANG | 2020 IEEE International Symposium on Radio-Frequency Integration Technology, RFIT 2020 | 0 | 0 | |
2022 | An AC-Coupling Parallel Hybrid Supply Modulator Achieving 100MHz Envelope Tracking Power Amplifiers for Wireless Communications | Hsiung P.-Y; Tsai C.-J; Chen Y.-M; CHING-JAN CHEN | Conference Proceedings - IEEE Applied Power Electronics Conference and Exposition - APEC | 0 | 0 | |
2016 | Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: Phase III randomized LUX-Lung 5 trial | Schuler M; CHIH-HSIN YANG ; Park K; Kim J.-H; Bennouna J; Chen Y.-M; Chouaid C; De Marinis F; Feng J.-F; Grossi F; Kim D.-W; Liu X; Lu S; Strausz J; Vinnyk Y; Wiewrodt R; Zhou C; Wang B; Chand V.K; Planchard D; Bagnes C; Martin C.M; Recondo G; Zarba J.J; Blajman C; Richardet M; McLachlan S.-A; Parente P; Underhill C; Crombie C; Mainwaring P; Greil R; Humblet Y; Bustin F; Carestia L; Galdermans D; Lambrechts M; Delval L; Vercauter P; Zhou C; Wang J; Huang C; Lin X; Wu Y; Liu X; Cheng Y; Qin S; Feng J; Huang J; Zhang Y; Lu S; Zereu M; Garicochea B; Zadra C.A; Riska H; Alanko T; Cadranel J; Chouaid C; Zalcman G; Sibilot D.M; Perol M; Planchard D; Bennouna J; Fournel P; Gervais R; Rotarski M; Coudert B; Thomas M; Wehler T; Faehling M; Keilholz U; Laack E; Von Pawel J; Huber R; Dickgreber N; Wiewrodt R; Mark Z; Tehenes S; Strausz J; Sarosi V; Prabhash K; Jain M; Venkatesan S; Sharma L; Dadhich H; Nagarkar R.V; Onn A; Gottfried M; Stemmer S; Migliorino M.R; Bidoli P; Bearz A; Gridelli C; Milandri C; Platania M; Ceresoli G.L; Cruciani G; Delgado F.G; Perez J.L.G; Luna G.A; Baca O.P; Aerts J; Stigt J; Dingemans A.-M; Herder G; Gans S; Sánchez J.F.S; Barreda R.L.A; Pantigoso W.R; Palomino O.L.M; Jaskiewicz P; Kazarnowicz A; Serwatowski P; Szczesna A; Jassem J; Lubennikov V; Karaseva N; Orlov S; Ragulin Y; Garrido P; Larriba J.L.G; Camps C; Campelo R.G; Lianes P; Cobo M; Felip E; Kim D.-W; Kim S.-W; Park K; Kim J.-H; Han J.-Y; Kim Y.-C; Yang C.-H; Hsia T.-C; Chen Y.-M; Tsai Y.-H; Chang G.-C; Tsao T.C.-Y; Su W.-C; Huang M.-S; Ho C.-L; Hsieh R.-K; Vinnyk Y; Popovych O; Ponomarova O; Bondarenko I; Polishchuk I; Shah R; Mitra S; Popat S; Spicer J; Toy E; Talbot T; Brown E; Upadhyay S; Summers Y; Gurtler J; Meza L; Thropay J; LUX-Lung 5 Investigators | Annals of Oncology | 118 | 110 | |
2012 | Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): A phase 2b/3 randomised trial | Miller V.A; Hirsh V; Cadranel J; Chen Y.-M; Park K; Kim S.-W; Zhou C; Su W.-C; Wang M; Sun Y; Heo D.S; Crino L; Tan E.-H; Chao T.-Y; Shahidi M; Cong X.J; Lorence R.M; CHIH-HSIN YANG | The Lancet Oncology | 879 | 785 | |
2019 | Assessing landslide characteristics in a changing climate in northern Taiwan | CHI-WEN CHEN ; Tung Y.-S; Liou J.-J; Li H.-C; Cheng C.-T; Chen Y.-M; Oguchi T. | Catena | 29 | 24 | |
2018 | Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study | Garassino M.C; Cho B.-C; Kim J.-H; Mazières J; Vansteenkiste J; Lena H; Corral Jaime J; Gray J.E; Powderly J; Chouaid C; Bidoli P; Wheatley-Price P; Park K; Soo R.A; Huang Y; Wadsworth C; Dennis P.A; Rizvi N.A; Paz-Ares Rodriguez L; Novello S; Hiret S; Schmid P; Laack E; Califano R; Maemondo M; Kim S.-W; Chaft J; Vicente Baz D; Berghmans T; Kim D.-W; Surmont V; Reck M; Han J.-Y; Holgado Martin E; Belda Iniesta C; Oe Y; Chella A; Chopra A; Robinet G; Soto Parra H; Thomas M; Cheema P; Katakami N; Su W.-C; Kim Y.-C; Wolf J; Lee J.-S; Saka H; Milella M; Ramos Garcia I; Sibille A; Yokoi T; Kang E.J; Atagi S; Spaeth-Schwalbe E; Nishio M; Imamura F; Gabrail N; Veillon R; Derijcke S; Maeda T; Zylla D; Kubiak K; Santoro A; Uy M.N; Lucien Geater S; Italiano A; Kowalski D; Barlesi F; Chen Y.-M; Spigel D; Chewaskulyong B; Garcia Gomez R; Alvarez Alvarez R; CHIH-HSIN YANG ; Hsia T.-C; Denis F; Sakai H; Vincent M; Goto K; Bosch-Barrera J; Weiss G; Canon J.-L; Scholz C; Aglietta M; Kemmotsu H; Azuma K; Bradbury P; Feld R; Chachoua A; Jassem J; Juergens R; Palmero Sanchez R; Malcolm A; Vrindavanam N; Kubota K; Waller C; Waterhouse D; Coudert B; Mark Z; Satouchi M; Chang G.-C; Herzmann C; Chaudhry A; Giridharan S; Hesketh P; Ikeda N; Boccia R; Iannotti N; Haigentz M; Reynolds J; Querol J; Nakagawa K; Sugawara S; Tan E.H; Hirashima T; Gettinger S; Kato T; Takeda K; Juan Vidal O; Mohn-Staudner A; Panwalkar A; Daniel D; Kobayashi K; Ladrera G.E.I; Schulte C; Sebastian M; Cernovska M; Coupkova H; Havel L; Pauk N; Singh J; Murakami S; Csoszi T; Losonczy G; Price A; Anderson I; Iqbal M; Torri V; Juhasz E; Khanani S; Koubkova L; Levy B; Page R; Bocskei C; Crinò L; Einspahr D; Hagenstad C; Juat N; Overton L; Garrison M; Szalai Z; ATLANTIC Investigators | The Lancet Oncology | 468 | 397 | |
2018 | The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib | Vishwanathan K; Dickinson P.A; So K; Thomas K; Chen Y.-M; De Castro Carpeño J; Dingemans A.-M.C; Kim H.R; Kim J.-H; Krebs M.G; Chih-Hsin CHIH-HSIN YANG ; Bui K; Weilert D; Harvey R.D. | British Journal of Clinical Pharmacology | 45 | 42 | |
2020 | Future landslide characteristic assessment using ensemble climate change scenarios: A case study in Taiwan | Chen Y.-M; CHI-WEN CHEN ; Chao Y.-C; Tung Y.-S; Liou J.-J; Li H.-C; Cheng C.-T. | Water (Switzerland) | 8 | 8 | |
2011 | Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS) | Thongprasert S; Duffield E; Saijo N; Wu Y.-L; CHIH-HSIN YANG ; Chu D.-T; Liao M; Chen Y.-M; Kuo H.-P; Negoro S; Lam K.C; Armour A; Magill P; Fukuoka M. | Journal of Thoracic Oncology | 120 | 107 | |
2020 | Highly Integrated ZVS Flyback Converter ICs with Pulse Transformer to Optimize USB Power Delivery for Fast-Charging Mobile Devices | Chang W.-H; Chen Y.-M; Chen C.-J; Wang P.-Y; Lin K.-Y; Lee C.-C; Lo L.-D; Lin J.-Y.G; Yang T.-Y.; CHING-JAN CHEN | IEEE Journal of Solid-State Circuits | | | |
2022 | An Integrated Driver With Adaptive Dead-Time Control for GaN-Based Synchronous Buck Converter | Chen C.-J; Chiu P.-K; Chen Y.-M; Wang P.-Y; Chang Y.-C.; CHING-JAN CHEN | IEEE Transactions on Circuits and Systems II: Express Briefs | | | |
2022 | An Integrated Driver With Bang-Bang Dead-Time Control and Charge Sharing Bootstrap Circuit for GaN Synchronous Buck Converter | CHING-JAN CHEN ; Wang P.-Y; Li S.-T; Chen Y.-M; Chang Y.-C. | IEEE Transactions on Power Electronics | 7 | 6 | |
2021 | Metabolic Alterations in Shrimp Stomach During Acute Hepatopancreatic Necrosis Disease and Effects of Taurocholate on Vibrio parahaemolyticus | Kumar R; Tung T.-C; Ng T.H; Chang C.-C; Chen Y.-L; Chen Y.-M; SHIH-SHUN LIN | Frontiers in Microbiology | | | |
2022 | Preliminary establishment of a mass movement warning system for Taiwan using the soil water index | CHI-WEN CHEN ; HONGEY CHEN ; Lin G.-W; Liou J.-J; Lin S.-Y; Li H.-C; Chen Y.-M; Chen H. | Landslides | 3 | 3 | |
2012 | Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer | Ahn M.-J; CHIH-HSIN YANG ; Liang J; Kang J.-H; Xiu Q; Chen Y.-M; Blair J.M; Peng G; Linn C; Orlando M. | Lung Cancer | 22 | 21 | |
2022 | Screening of Lactic Acid Bacterial Strains with Antiviral Activity Against Porcine Epidemic Diarrhea | Chen Y.-M; Limaye A; HUI-WEN CHANG ; JE-RUEI LIU | Probiotics and Antimicrobial Proteins | 6 | 2 | |
2010 | Understanding what concerns consumers: A semantic approach to product feature extraction from consumer reviews | CHIH-PING WEI ; Chen Y.-M; Yang C.-S; Yang, Christopher C. | Information Systems and e-Business Management | 87 | 64 | |